152 related articles for article (PubMed ID: 8722341)
1. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders. Current practice in Europe in 1996 and proposals for an operational classification. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT).
Schmitz N; Gratwohl A; Goldman JM
Bone Marrow Transplant; 1996 Apr; 17(4):471-7. PubMed ID: 8722341
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Urbano-Ispizua A; Schmitz N; de Witte T; Frassoni F; Rosti G; Schrezenmeier H; Gluckman E; Friedrich W; Cordonnier C; Socie G; Tyndall A; Niethammer D; Ljungman P; Gratwohl A; Apperley J; Niederwieser D; Bacigalupo A;
Bone Marrow Transplant; 2002 Apr; 29(8):639-46. PubMed ID: 12180107
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation.
Goldman JM; Schmitz N; Niethammer D; Gratwohl A
Bone Marrow Transplant; 1998 Jan; 21(1):1-7. PubMed ID: 9486487
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Ljungman P; Urbano-Ispizua A; Cavazzana-Calvo M; Demirer T; Dini G; Einsele H; Gratwohl A; Madrigal A; Niederwieser D; Passweg J; Rocha V; Saccardi R; Schouten H; Schmitz N; Socie G; Sureda A; Apperley J;
Bone Marrow Transplant; 2006 Mar; 37(5):439-49. PubMed ID: 16444286
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.
Ljungman P; Bregni M; Brune M; Cornelissen J; de Witte T; Dini G; Einsele H; Gaspar HB; Gratwohl A; Passweg J; Peters C; Rocha V; Saccardi R; Schouten H; Sureda A; Tichelli A; Velardi A; Niederwieser D;
Bone Marrow Transplant; 2010 Feb; 45(2):219-34. PubMed ID: 19584824
[TBL] [Abstract][Full Text] [Related]
6. Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey.
Gratwohl A; Baldomero H; Passweg J; Urbano-Ispizua A;
Bone Marrow Transplant; 2002 Dec; 30(12):813-31. PubMed ID: 12476273
[TBL] [Abstract][Full Text] [Related]
7. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1998 Aug; 22(3):227-40. PubMed ID: 9720735
[TBL] [Abstract][Full Text] [Related]
8. Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J; Baldomero H
Bone Marrow Transplant; 1997 Mar; 19(5):407-19. PubMed ID: 9052905
[TBL] [Abstract][Full Text] [Related]
9. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
[TBL] [Abstract][Full Text] [Related]
10. Incidence of bone marrow transplantation in Europe. Report from the European Group for Blood and Marrow Transplantation.
Gratwohl A
Arch Immunol Ther Exp (Warsz); 1995; 43(2):77-81. PubMed ID: 8744719
[TBL] [Abstract][Full Text] [Related]
11. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C
Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797
[TBL] [Abstract][Full Text] [Related]
12. Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey.
Gratwohl A; Schmid O; Baldomero H; Horisberger B; Urbano-Ispizua A;
Bone Marrow Transplant; 2004 Nov; 34(10):855-75. PubMed ID: 15517006
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplantation activity in Europe 1999.
Gratwohl A; Passweg J; Baldomero H; Urbano-Ispizua A;
Bone Marrow Transplant; 2001 May; 27(9):899-916. PubMed ID: 11436100
[TBL] [Abstract][Full Text] [Related]
14. Stem cell transplantation in Europe: trends and prospects.
Tan SS; Uyl-de Groot CA; Huijgens PC; Fibbe WE
Eur J Cancer; 2007 Nov; 43(16):2359-65. PubMed ID: 17919900
[TBL] [Abstract][Full Text] [Related]
15. Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019.
Duarte RF; Labopin M; Bader P; Basak GW; Bonini C; Chabannon C; Corbacioglu S; Dreger P; Dufour C; Gennery AR; Kuball J; Lankester AC; Lanza F; Montoto S; Nagler A; Peffault de Latour R; Snowden JA; Styczynski J; Yakoub-Agha I; Kröger N; Mohty M;
Bone Marrow Transplant; 2019 Oct; 54(10):1525-1552. PubMed ID: 30953028
[TBL] [Abstract][Full Text] [Related]
16. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D; ;
Bone Marrow Transplant; 2008 Apr; 41(8):687-705. PubMed ID: 18084334
[TBL] [Abstract][Full Text] [Related]
17. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.
Gratwohl A; Baldomero H; Schmid O; Horisberger B; Bargetzi M; Urbano-Ispizua A
Bone Marrow Transplant; 2005 Oct; 36(7):575-90. PubMed ID: 16086045
[TBL] [Abstract][Full Text] [Related]
18. EBMT activity survey 2004 and changes in disease indication over the past 15 years.
Gratwohl A; Baldomero H; Frauendorfer K; Urbano-Ispizua A; ;
Bone Marrow Transplant; 2006 Jun; 37(12):1069-85. PubMed ID: 16757972
[TBL] [Abstract][Full Text] [Related]
19. Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation.
Miano M; Labopin M; Hartmann O; Angelucci E; Cornish J; Gluckman E; Locatelli F; Fischer A; Egeler RM; Or R; Peters C; Ortega J; Veys P; Bordigoni P; Iori AP; Niethammer D; Rocha V; Dini G;
Bone Marrow Transplant; 2007 Jan; 39(2):89-99. PubMed ID: 17213848
[TBL] [Abstract][Full Text] [Related]
20. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]